1-4 of 4
Keywords: Myelodysplastic syndromes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Diagnosis and Therapy of Myelodysplastic Syndromes in Germany: A Retrospective Multicenter Analysis

Subject Area:
Oncology
Norbert Gattermann, Andrea Kündgen, Lenka Kellermann, Matti Zeffel, Bernadette Paessens, Ulrich Germing
Journal: Onkologie
Onkologie (2012) 35 (6): 350–356.
https://doi.org/10.1159/000338939
Published Online: 25 May 2012
...Norbert Gattermann; Andrea Kündgen; Lenka Kellermann; Matti Zeffel; Bernadette Paessens; Ulrich Germing Background: Myelodysplastic syndromes (MDS) are a heterogenous group of clonal hematopoietic stem cell disorders. Patients and Methods: In order to assess current diagnosis and treatment patterns...
View article titled, Diagnosis and Therapy of <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndromes</span> in Germany: A Retrospective Multicenter Analysis
Open the PDF for Diagnosis and Therapy of <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndromes</span> in Germany: A Retrospective Multicenter Analysis in another window
Journal Articles

Phase II Study of Subcutaneous Erythropoietin for Treatment of Myelodysplastic Syndromes (FAB Type I and II): A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society: A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society

Subject Area:
Oncology
G. Hartung, A. Weigold, S. Öhl, U. Essers, M.E. Heim, D. Fritze, M. Baldus, D. Hoelzer, K. Bremer, O. Quarder, L. Edler, W. Queißer
Journal: Onkologie
Onkologie (1995) 18 (5): 451–455.
https://doi.org/10.1159/000218634
Published Online: 11 May 2009
...G. Hartung; A. Weigold; S. Öhl; U. Essers; M.E. Heim; D. Fritze; M. Baldus; D. Hoelzer; K. Bremer; O. Quarder; L. Edler; W. Queißer Background : Anemia in patients with myelodysplastic syndromes (MDS) is usually put down to ineffective erythropoiesis, although the contributory role of other...
View article titled, Phase II Study of Subcutaneous Erythropoietin for Treatment of <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndromes</span> (FAB Type I and II): A Trial of the Phase l&#x2F;ll Study Group of the Association for Medical Oncology of the German Cancer Society: A Trial of the Phase l&#x2F;ll Study Group of the Association for Medical Oncology of the German Cancer Society
Open the PDF for Phase II Study of Subcutaneous Erythropoietin for Treatment of <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndromes</span> (FAB Type I and II): A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society: A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society in another window
Journal Articles

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor and Low-Dose Cytosine Arabinoside in Patients with Myelodysplastic Syndrome: A Pilot Study

Subject Area:
Oncology
A. Ganser, O.G. Ottmann, G. Schulz, D. Hoelzer
Journal: Onkologie
Onkologie (1989) 12 (1): 13–15.
https://doi.org/10.1159/000216589
Published Online: 27 April 2009
...A. Ganser; O.G. Ottmann; G. Schulz; D. Hoelzer In a pilot study, five patients with myelodysplastic syndromes with an excess of blast cells were treated with a combination of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and low-dose cytosine-arabinoside (ara-C...
View article titled, Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor and Low-Dose Cytosine Arabinoside in Patients with <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndrome</span>: A Pilot Study
Open the PDF for Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor and Low-Dose Cytosine Arabinoside in Patients with <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndrome</span>: A Pilot Study in another window
Journal Articles

Myelodysplastic Syndromes: Aspects of Current Medical Care and Economic Considerations in Germany

Subject Area:
Oncology
Norbert Gattermann, Wolf-Karsten Hofmann, Axel Meeßen, Stephan Schmitz, Anton Tsamaloukas, Tanja Vollmer, Ulrich Wedding, Carlotta Plesnila-Frank, Wolfgang Schramm, Karin Berger
Journal: Onkologie
Onkologie (2008) 31 (8-9): 477–484.
https://doi.org/10.1159/000142900
Published Online: 31 July 2008
...Norbert Gattermann; Wolf-Karsten Hofmann; Axel Meeßen; Stephan Schmitz; Anton Tsamaloukas; Tanja Vollmer; Ulrich Wedding; Carlotta Plesnila-Frank; Wolfgang Schramm; Karin Berger Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases mainly affecting older people. The use...
View article titled, <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndromes</span>: Aspects of Current Medical Care and Economic Considerations in Germany
Open the PDF for <span class="search-highlight">Myelodysplastic</span> <span class="search-highlight">Syndromes</span>: Aspects of Current Medical Care and Economic Considerations in Germany in another window